Strategies for Success: Using Long-Acting Injectable Medications-Lecture Presentation

Video Transcription

Video Summary

In this video, Dr. Yvonne Yang discusses the use of long-acting injectable medications (LAIs) for the treatment of serious mental illness. She begins by discussing the benefits of LAIs, including their ability to improve adherence, decrease symptoms, reduce rehospitalization rates, and decrease mortality. Dr. Yang explains that LAIs are a flexible and effective treatment option for patients who struggle with adherence to oral medication. She provides information on different types of LAIs, such as risperidone, paliperidone, aripiprazole, and olanzapine, and the dosing options available for each. <br /><br />Dr. Yang also addresses common concerns and misconceptions about LAIs, such as fear of needles, loss of control, and the stigma associated with receiving injections. She emphasizes that LAIs can provide patients with better control over their illness and can be tailored to meet individual needs. Dr. Yang offers practical strategies for addressing barriers to using LAIs, including working with pharmaceutical companies to obtain financial assistance or insurance coverage, utilizing resources like the SMI Advisor Long-Acting Injectable Center of Excellence, and becoming comfortable with administering injections.<br /><br />Overall, Dr. Yang highlights the effectiveness and flexibility of LAIs in the treatment of serious mental illness and encourages clinicians to consider them as a valuable treatment option for their patients.

Keywords

Dr. Yvonne Yang

long-acting injectable medications

serious mental illness

improve adherence

reduce rehospitalization rates

risperidone

aripiprazole

SMI Advisor Long-Acting Injectable Center of Excellence